Danielle Porter

Gilead Sciences, Inc.

333 Lakeside Dr

Foster City, CA 94404

United States

SCHOLARLY PAPERS

3

DOWNLOADS

151

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Characterization of Ebola Virus from an Ongoing Outbreak in Ituri and North Kivu, DR Congo to Guide to Response Activities

Number of pages: 30 Posted: 18 Apr 2019
Government of the United States of America - Viral Special Pathogens Branch, Government of the United States of America - Viral Special Pathogens Branch, Government of the United States of America - Viral Special Pathogens Branch, Government of the United States of America - Viral Special Pathogens Branch, Government of the United States of America - Viral Special Pathogens Branch, Gilead Sciences, Inc., Government of the United States of America - Viral Special Pathogens Branch, Government of the United States of America - Viral Special Pathogens Branch and Government of the United States of America - Viral Special Pathogens Branch
Downloads 88 (413,000)

Abstract:

Loading...

Virus, outbreak, epidemiology, Ebola, public health

2.

Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fixed-Dose Combination for Treatment of HIV in Adolescents and Children: Week 48 Results from an Open-Label, Multicentre, Phase 2/3 Paediatric Trial

Number of pages: 35 Posted: 01 Sep 2020
Department of Infectious Diseases, St. Jude Children’s Research Hospital, Stellenbosch University, Department of Pediatrics, Division of Infectious Diseases, University of South Florida, Department of Pediatrics at the Wayne State University School of Medicine, Be Part Yoluntu Centre, Chris Hani Baragwanath Academic Hospital, Joint Clinical Research Centre, Faculty of Medicine, Khon Kaen University, Mahidol University - Siriraj Institute of Clinical Research (SICRES), Department of Portfolio Project Management, Gilead Sciences, Gilead Sciences, Inc., Gilead Sciences, Inc., Department of Clinical Pharmacology, Gilead Sciences, Department of Virology Clinical Research, Gilead Sciences, Federal Reserve Banks - Federal Reserve Bank of Cleveland, Gilead Sciences, Inc. and Department of Virology Clinical Research, Gilead Science
Downloads 37 (620,239)

Abstract:

Loading...

paediatric, HIV, INSTI, bictegravir, tenofovir alafenamide

3.

Remdesivir Potently Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Number of pages: 28 Posted: 11 May 2020
Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Vanderbilt University - Department of Pediatrics and University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology
Downloads 26 (692,935)
Citation 10

Abstract:

Loading...

COVID-19, SARS-Cov-2, coronavirus, antivirals, remdesivir, RdRp, RNA-dependent RNA polymerase, therapeutic, mouse